Tessera
Folgen

Parag Bawaskar

@paragbawaskar.bsky.social

Cardiologist, Post Doctoral Research Associate, Cardiovascular Division, University of Minnesota Medical School.

33 Posts626 Follower182 Folgt
Parag Bawaskar@paragbawaskar.bsky.social · 8mo ago

APERITIF tested low-dose rivaroxaban+ DAPT vs DAPT alone to prevent LV thrombus after anterior STEMI. Primary endpoint: LVT on contrast-enhanced CMR at 1 month. Result: no significant difference (13.7% vs 16.6%, p=.34).But there's a screening problem worth discussing. jamanetwork.com/journals/jam...

Low-Dose Rivaroxaban to Prevent Left Ventricular Thrombosis After Anterior Myocardial Infarction

This multicenter randomized clinical trial conducted in France determines whether the addition of low-dose rivaroxaban to dual antiplatelet therapy reduces the incidence of left ventricular thrombus a...

jamanetwork.com

Chetan Shenoy@cshenoy.bsky.social · 2y ago

Read our accompanying editorial for our thoughts on the important paper – academic.oup.com/ehjcimaging/... @paragbawaskar.bsky.social #CardioSky #MedSky #Sarcoidosis

Cardiac FDG-PET imaging in patients with suspected cardiac sarcoidosis and no late gadolinium enhancement on cardiovascular magnetic resonance imaging: the emperor has no clothes!

This editorial refers to ‘The Role of FDG PET/CT in Assessing Cardiac Sarcoidosis with No High-Risk Cardiac Features and Normal CMR’, by F. Shuduyeva et al

academic.oup.com

Chetan Shenoy@cshenoy.bsky.social · 2y ago

This paper reports the coexistence of cardiac sarcoidosis and arrhythmogenic cardiomyopathy in 5 patients. heart.bmj.com/content/earl... #CardioSky #MedSky

Coexistence of cardiac sarcoidosis and arrhythmogenic cardiomyopathy-associated genetic variants: a multicentre case-control study

Background Cardiac sarcoidosis (CS) is a chronic inflammatory disease characterised by non-caseating granulomas, while arrhythmogenic cardiomyopathy (ACM) is a genetic condition mainly affecting desmo...

heart.bmj.com

Lars Mølgaard Saxhaug@load-dependent.eurosky.social · 2y ago

It’s great that journals are coming over here, but what I have really missed after my departure from Twitter 2 years ago is this, the authors themselves presenting their works and discussing it with peers. #cardiosky #medsky #emimcc

Chetan Shenoy@cshenoy.bsky.social · 2y ago

In 2019, we wrote a paper showing that patients with left ventricular thrombus have a long-term risk of embolism, extending to at least 8 years. We were puzzled by the finding… #CardioSky www.ahajournals.org/doi/10.1161/...

Figure 2 from the paper. Incidence of embolism in left ventricular (LV) thrombus patients compared with matched non-LV thrombus patients. Kaplan-Meier curves demonstrate the cumulative incidence of the composite embolic end point in the LV thrombus (in red) and in the matched non-LV thrombus (in blue) groups. Note the significant difference in the cumulative incidence of embolic events between the 2 groups.